Dueling Ad Challenges Signal “Healthy” Competition – NAD
This article was originally published in The Tan Sheet
Executive Summary
The volley between Matrixx Initiatives and ProPhase Labs is the latest examples of competing firms both filing claim challenges with the Council of Better Business Bureaus. Challenged by competitors, firms will “bring the best science to the table,” says CBBB’s Linda Bean.
You may also be interested in...
People In Brief
Herbalife brings on Dentali as botanical sciences VP; NACDS expands Nicholson’s role; Innophos announces interim CFO; George Hamilton new face of Infusion Life Sciences; Aker BioMarine names sales VP; Atteryd to chair Food Supplements Europe.
FDA Details “Quality Agreements” For Marketers, Contract Manufacturers
The “Contract Manufacturing Arrangements for Drugs: Quality Agreements” draft guidance describes how parties involved in contract manufacturing of drugs can employ quality agreements to delineate their responsibilities and ensure drug quality, safety and efficacy.
FDA Details “Quality Agreements” For Marketers, Contract Manufacturers
The “Contract Manufacturing Arrangements for Drugs: Quality Agreements” draft guidance describes how parties involved in contract manufacturing of drugs can employ quality agreements to delineate their responsibilities and ensure drug quality, safety and efficacy.